Verona Pharma's market cap is currently $9.19B. The company's EPS TTM is $-0.005; its P/E ratio is ―; Verona Pharma is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $0.14. See an overview of income statement, balance sheet, and cash flow financials.
